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he release of cytochrome 
 
c
 
 from mitochondria is
necessary for the formation of the Apaf-1 apoptosome
and subsequent activation of caspase-9 in mammalian
cells. However, the role of cytochrome 
 
c
 
 in caspase activation
in 
 
Drosophila
 
 cells is not well understood. We demonstrate
 
here that cytochrome 
 
c
 
 remains associated with mitochondria
during apoptosis of 
 
Drosophila
 
 cells and that the initiator
caspase DRONC and effector caspase DRICE are activated
after various death stimuli without any significant release
of cytochrome 
 
c
 
 in the cytosol. Ectopic expression of the
proapoptotic Bcl-2 protein, DEBCL, also fails to show any
T
 
cytochrome 
 
c
 
 release from mitochondria. A significant
proportion of cellular DRONC and DRICE appears to localize
near mitochondria, suggesting that an apoptosome may
form in the vicinity of mitochondria in the absence of
cytochrome 
 
c
 
 release. In vitro, DRONC was recruited to a
 

 
700-kD complex, similar to the mammalian apoptosome
in cell extracts supplemented with cytochrome 
 
c
 
 and dATP.
These results suggest that caspase activation in insects follows
a more primitive mechanism that may be the precursor to
the caspase activation pathways in mammals.
 
Introduction
 
Programmed cell death by apoptosis is a common way for
deleting unwanted and superfluous cells (for review see Vaux
and Korsmeyer, 1999). Apoptosis is mediated by a group of
cysteine proteases, termed caspases (for review see Nicholson,
1999). Caspases, which cleave their substrates after an aspar-
tate residue, are normally present as inactive precursors in
cells. Upon receiving an apoptotic signal, the pro-forms
(zymogens) of caspases undergo proteolytic processing to
generate active enzyme (for reviews see Kumar, 1999; Kumar
and Colussi, 1999; Nicholson, 1999; Wang, 2001). In
mammals there are 13 caspases, some of which are involved
in apoptosis, whereas others are believed to be primarily
responsible for the activation and regulation of proinflam-
matory cytokines (Nicholson, 1999). There are a total of
seven caspases in 
 
Drosophila melanogaster
 
: DCP-1, DREDD,
DRICE, DRONC, DECAY, DAMM, and STRICA (Fraser
and Evan, 1997; Song et al., 1997; Chen et al., 1998;
Dorstyn et al., 1999a,b; Doumanis et al., 2001; Harvey et
al., 2001). Of these caspases, DRONC, DREDD, DCP-1,
and DRICE have been shown to play a role in the execution
of cell death (Fraser and Evan, 1997; Fraser et al., 1997;
Song et al., 1997; Chen et al., 1998; McCall and Stellar,
1998; Dorstyn et al., 1999a,b; Hawkins et al., 2000; for re-
view see Kumar and Doumanis, 2000; Meier et al., 2000;
Quinn et al., 2000).
DRONC is the only 
 
Drosophila
 
 caspase that contains a
caspase recruitment domain, suggesting that it is the func-
tional counterpart of CED-3 in 
 
Caenorhabditis elegans
 
 and
caspase-9 in mammals (Dorstyn et al., 1999a). Genetic and
gene ablation experiments have demonstrated that DRONC
is essential for programmed cell death during development
and is required for cell death in the fly eye, mediated by
Reaper, Hid, and Grim (Hawkins et al., 2000; Meier et al.,
2000; Quinn et al., 2000). DRONC interacts with and pro-
cesses the effector caspase DRICE, suggesting that DRONC
is an initiator caspase (Hawkins et al., 2000; Kumar and
Doumanis, 2000; Meier et al., 2000). Furthermore, 
 
dronc
 
transcript is massively up-regulated in larval salivary glands
and midgut by the hormone ecdysone, which mediates
programmed deletion of larval tissues during larval/pu-
pal metamorphosis (Dorstyn et al., 1999a,b; Baehrecke,
2000). Although the biochemical mechanism of DRONC
activation is not well understood, genetic studies demon-
strate that DARK/Dapaf-1/HAC-1, the 
 
Drosophila
 
 CED-4/
Apaf-1 homologue, is required for DRONC-mediated cell
death (Quinn et al., 2000), suggesting that a DARK–DRONC
complex may be necessary for initial autocatalytic activation
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of DRONC. In support of this model, DRONC has been
shown to interact with DARK in a caspase recruitment do-
main–dependent manner (Quinn et al., 2000).
In mammals, cellular stress signals lead to the release of
mitochondrial cytochrome 
 
c
 
, which binds to and enables oli-
gomerization of the adaptor protein Apaf-1 (Li et al., 1997;
Zou et al., 1997, 1999). Apaf-1, in turn, recruits the precur-
sor form of caspase-9, an apical caspase, and thereby pro-
motes its proximity-induced autocatalytic activation (Li et
al., 1997; Zou et al., 1997, 1999). The requirement of cyto-
chrome 
 
c
 
 in caspase activation is well documented in mam-
mals. In mice in which the cytochrome 
 
c
 
 gene has been de-
leted by homologous recombination, the caspase-9–Apaf-1
pathway is severely impaired (Li et al., 2000). In contrast, in
 
C
 
.
 
 elegans
 
, there is no published evidence that CED-4–medi-
ated CED-3 activation requires cytochrome 
 
c
 
, suggesting
that cytochrome 
 
c
 
 function in apoptosis may have evolved
later in more complex organisms.
The role of cytochrome 
 
c
 
 in 
 
Drosophila
 
 caspase activation is
not well established. Structurally, DARK is more similar to its
mammalian counterpart Apaf-1 than to CED-4, in that it
contains several WD40 repeats that are not found in CED-4,
and it binds cytochrome 
 
c
 
 in vitro (Kanuka et al., 1999; Rod-
riguez et al., 1999; Zhou et al., 1999). However, it is unclear
whether the 
 
Drosophila
 
 protein requires cytochrome 
 
c
 
 for its
oligomerization. Kanuka et al. (1999) have shown that addi-
tion of cytochrome 
 
c
 
 and dATP to 
 
Drosophila
 
 embryo extracts
results in a twofold enhancement of DEVDase activity, which
was not seen in extracts prepared from 
 
dapaf-1
 
 mutant em-
bryos. The cytochrome 
 
c
 
/dATP–induced caspase activity was
also inhibited by an ATPase inhibitor, suggesting that the ATP-
ase activity of Dapaf-1 may be necessary for its ability to medi-
ate caspase activation (Kanuka et al., 1999).
There are conflicting reports of cytochrome 
 
c
 
 release from
the mitochondria of 
 
Drosophila
 
 cells during apoptosis. In
 
Drosophila
 
 SL2 cells, overexpression of 
 
rpr
 
 or treatment with
staurosporine or cycloheximide causes an apparent release of
cytochrome 
 
c
 
 into the cytosol (Kanuka et al., 1999). On the
other hand, Varkey et al. (1999) demonstrated an alteration
in cytochrome 
 
c
 
 conformation, as evidenced by display of an
otherwise hidden epitope, in 
 
Drosophila
 
 tissues preceding
apoptosis. This alteration occurs without release of the pro-
tein into the cytosol. In cell-free studies, caspase activation
was triggered by mitochondria from apoptotic cells but not
by those from healthy cells. These observations suggest that
in the fly, the function of cytochrome 
 
c
 
 in caspase activation
may be somewhat different from its role in mammalian cells.
If cytochrome 
 
c
 
 is not released from mitochondria, it is un-
clear if it is required for caspase activation in vivo. The anal-
ysis of endogenous 
 
Drosophila
 
 caspases has been limited due
to a lack of appropriate antibodies.
In this paper, we have investigated whether cytochrome
 
c
 
 release from mitochondria is necessary for the activation
of key 
 
Drosophila
 
 apoptotic caspases, i.e., DRONC and
DRICE. Using specific antibodies, we demonstrate that dur-
ing apoptosis, DRONC and DRICE are rapidly processed
without any cytochrome 
 
c
 
 release from mitochondria. We
also show that in cell-free extracts, both DRONC and
DRICE are recruited to a 
 

 
700-kD complex, which is pre-
sumably required for their activation.
 
Results
 
DRONC is activated early during apoptosis of
ML-DmBG2c2 (BG2) cells
 
For most studies reported in this paper, we have used ML-
DmBG2c2 (BG2)* cells derived from the 
 
Drosophila
 
 larval
central nervous system (Ui-Tei et al., 2000). The main ad-
vantage of using these cells is that, unlike the commonly
used SL2 cells, BG2 cells are adherent and have a flatter
morphology to allow subcellular localization studies not eas-
ily done in SL2 cells. BG2 cells undergo classical caspase-
dependent apoptosis after treatment with a number of
agents and serum/factor withdrawal (Ui-Tei et al., 2000). The
kinetics of cell death by treatment with cycloheximide is rapid.
Dying cells become morphologically distinguishable within
2–4 h and appreciable caspase activity is detectable at 4 h
(Fig. 1 A). DRONC is an apical caspase in the fly, and pre-
vious studies from our laboratory, and those of others, have
demonstrated that DRONC is essential for developmentally
programmed cell death (Dorstyn et al., 1999a; Hawkins et
al., 2000; Meier et al., 2000; Quinn et al., 2000). To test
whether DRONC is activated during apoptosis of BG2
cells, we used an affinity-purified DRONC polyclonal anti-
body to study DRONC processing. As shown in Fig. 1 B,
the 50-kD DRONC precursor was cleaved to a 36-kD (p36)
fragment that was not processed any further. DRONC pro-
cessing became apparent after 4 h of cycloheximide treat-
ment of BG2, and by 16 h all proDRONC was fully cleaved
to p36 fragment. Because DRONC antibody was raised
against the carboxyl terminus of the protein, the processing
data indicate that p36 represents the catalytic region of
DRONC devoid of the prodomain and suggest that
DRONC precursor is not processed into two subunits dur-
ing apoptosis. We have previously noted that the recombi-
nant prodomainless DRONC protein (p36) expressed in 
 
Esch-
erichia coli
 
 is significantly more active than the full-length
DRONC protein (p50) (Dorstyn et al., 1999a; unpublished
data). Interestingly, p36 does not undergo any significant
processing in 
 
E. coli
 
. These data suggest that p36 is likely to
be the active species in vivo. We also observed that DRONC
is processed only to p36 species in two other 
 
Drosophila
 
 cell
lines undergoing apoptosis (unpublished data). DRICE, an
effector caspase, is a downstream target of DRONC. There-
fore, we also analyzed DRICE processing in BG2 cells using
an antibody raised against the large subunit of DRICE. The
DRICE precursor was fully processed after 8 h of cyclohex-
imide treatment, as evidenced by the disappearance of the
35-kD precursor and appearance of the 19-kD large subunit
(Fig. 1 B). The withdrawal of serum and insulin from BG2
cell cultures resulted in slower death kinetics, with caspase
activation only becoming apparent after 16 h of factor with-
drawal (Fig. 1 C). Concomitant with caspase activity, de-
tectable DRONC processing was also seen 16 h after serum
withdrawal (Fig. 1 D). Some processing of proDRICE was
also seen around 16 and 24 h. However, full processing re-
quired longer incubation in serum-starved conditions (un-
 
*Abbreviations used in this paper: BG2, ML-DmBG2c2; GST, glu-
tathione-
 
S
 
-transferase; HA, hemagglutinin; RNAi, RNA-mediated inter-
ference; RT, room temperature.
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published data). These data indicate that activation of the
endogenous apical caspase DRONC and effector caspase
DRICE is associated with apoptosis in BG2 cells.
Genetic studies show that DARK is required for the
proapoptotic function of DRONC (Quinn et al., 2000).
To test whether DARK is necessary for caspase activation
in BG2 cells, we used double-stranded RNA–mediated in-
terference (RNAi) to ablate endogenous 
 
dark
 
 transcript.
Northern blot analysis suggested that 
 
dark
 
 RNAi caused a
significant reduction in 
 
dark
 
 mRNA in BG2 cells (unpub-
lished data). Exposure of BG2 cells with cycloheximide in
the presence of 
 
dark
 
 RNAi resulted in an inhibition of
DRONC and DRICE processing, suggesting that DARK
is necessary for caspase activation (Fig. 2). We also used
 
dronc
 
 RNAi to test whether reduction in the levels of en-
dogenous DRONC protein would affect DRICE pro-
cessing. 
 
dronc
 
 RNAi significantly reduced endogenous
DRONC protein in BG2 cells and resulted in an inhibi-
tion of DRICE processing in cells undergoing apoptosis
(Fig. 2). These results are consistent with DRONC being
an initiator caspase that mediates DRICE activation dur-
ing apoptosis.
 
DRONC and DRICE are activated without any 
apparent release of mitochondrial cytochrome 
 
c
 
To analyze the role of cytochrome 
 
c
 
 in DRONC activation,
we exposed BG2 cells to cycloheximide or serum withdrawal
for various lengths of time and subjected them to cell frac-
tionation. Cell fractions were then analyzed by immunoblot-
ting using cytochrome 
 
c
 
 and DRONC antibodies. As shown
in Fig. 3 A, the majority of DRONC was present in the
S100 (cytosolic) fraction and showed substantial processing
after treatment with cycloheximide, similar to that seen in
whole cell lysates. Interestingly, a significant fraction of en-
dogenous DRONC was found in the P10 fraction that con-
tains mitochondria, and to a lesser extent in the light mem-
brane P100 fraction that contains various types of ER- and
Golgi-derived vesicles, endosomes, etc. (Fig. 3 A). Both P10
and P100 fractions contained precursor and processed forms
of DRONC. The overall level of membrane-associated
DRONC protein remained unchanged after treatment with
cycloheximide. Similar to DRONC, the majority of DRICE
was present in the cytosolic fraction, with a small fraction as-
sociated with the heavy membrane fraction P10 (Fig. 3 A).
However, DRICE was not found in the P100 fraction. Blot-
ting of the same blots with a cytochrome 
 
c
 
 antibody showed
that cytochrome 
 
c
 
 was associated with the mitochondrial
fraction, and there was no apparent decrease in mitochon-
drial cytochrome 
 
c
 
 in cells treated with cycloheximide (Fig. 3
A), suggesting that cytochrome 
 
c
 
 was not being released
from the mitochondria in cells undergoing apoptosis. Con-
sistent with this observation, there was no cytochrome 
 
c
 
 de-
tected in the P100 or S100 fraction.
To test whether lack of cytochrome 
 
c
 
 release during
apoptosis is common to apoptosis induced by various forms
of stress, we performed experiments in which BG2 cells
were fractionated after withdrawal of serum and insulin for
various lengths of time. As the kinetics of cell death after se-
rum/insulin withdrawal are much slower than in cyclohex-
imide-treated cells (Fig. 1 C), it was possible to observe
subtle changes in protein levels in various fractions. As be-
fore, the majority of DRONC was present in the cytosolic
fraction, but significant amounts were also associated with
the P10 and P100 fractions (Fig. 3 B). Interestingly, we
could see a significant increase in membrane-associated
DRONC in cells exposed to serum-starved conditions for
16–24 h. Both processed and precursor forms of DRONC
were found in all fractions. As shown previously (Fig. 1 D),
most proDRICE remains in its precursor form 24 h after
serum withdrawal and was largely found in the cytosolic
fraction (Fig. 3 B). As in the case of cycloheximide-treated
BG2 cells, there was no apparent release of cytochrome 
 
c
 
from the mitochondrial fraction in cells exposed to serum-
free conditions (Fig. 3 B).
Figure 1. Caspase activation during apoptosis of BG2 cells. BG2 
cells were treated with cycloheximide (A and B) or deprived of 
serum and insulin (C and D) over 24 h. (A and C) At various times 
after apoptotic stimuli, cells were assayed for viability by trypan 
blue exclusion () and for caspase activity on either DEVD-amc () 
or VDVAD-amc (). To determine caspase processing, lysates from 
cycloheximide-treated (B) or serum- and/or insulin-starved (D) BG2 
cells were immunoblotted with anti-DRONC polyclonal antibody 
(top) or with an anti-DRICE polyclonal antibody (bottom) and 
proteins were visualized by enhanced chemiluminescence.
Figure 2. DARK is required for caspase activation in BG2 cells 
during apoptosis. BG2 cells were exposed to 37 nM of double 
stranded RNA for dronc, dark, or a negative control. Cells were 
either left untreated or treated with cycloheximide for 6 h. Cell lysates 
were immunoblotted using anti-DRONC and anti-DRICE antibodies.
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Cytochrome 
 
c
 
 remains associated with mitochondria in 
dying BG2 cells
 
To confirm our cell fractionation experiments, we per-
formed immunostaining of BG2 cells undergoing apopto-
sis. Staining with the mitochondrial marker MitoTracker
showed punctate staining that was similar to that seen with
cytochrome 
 
c
 
 staining (Fig. 4). Upon treatment with cy-
cloheximide, there were clear morphological changes in
treated cells that became evident at 4 h, however, the ma-
jority of the MitoTracker and cytochrome 
 
c
 
 staining was
still punctate. These results suggest that after treatment
with cycloheximide, mitochondria remain intact in dying
cells and the majority of the cytochrome 
 
c
 
 remains associ-
ated with mitochondria (Fig. 4). Staining of cells with the
cationic dye DiOC
 
6
 
 over 8 h indicated that mitochondrial
membrane potential is not altered in BG2 cells after cyclo-
heximide treatment (unpublished data). Staining of endog-
enous DRONC, using the affinity-purified DRONC anti-
body, showed that the majority of the protein is cytosolic
with some punctate staining that appears to become more
concentrated in the perinuclear regions of the cells treated
with cycloheximide (Fig. 4). We also determined the local-
ization of DRICE, a key downstream caspase activated by
DRONC (Meier et al., 2000). We used an antibody for
DRICE that detects only the processed form. As shown in
Fig. 4, at 0 h, there was little or no DRICE staining in
cells, but by 4 h, significant processed DRICE was de-
tected in BG2 cells. At 8 h, considerably more active
DRICE was evident, and in many cells it showed punctate
staining or appeared to have accumulated in large aggre-
gates (Fig. 4).
 
DRONC partly localizes in the vicinity of mitochondria 
in BG2 cells
 
To test whether DRONC colocalizes with mitochondria
and cytochrome 
 
c
 
, we performed double staining of BG2
cells. In untreated cells, a significant proportion of endoge-
nous DRONC was found to localize with mitochondria, as
detected by both MitoTracker (Fig. 5 A) or cytochrome 
 
c
 
(Fig. 5 B) costaining. Similar results were obtained when se-
rum withdrawal was used to induce apoptosis in BG2 cells
(Fig. 6 A). The kinetics of cell death due to serum with-
drawal are relatively slow (Fig. 1). Nonetheless, caspase acti-
vation, as measured using the processed DRICE–specific an-
tibody, was clearly visible (Fig. 6 B). Interestingly, some
active DRICE also appeared to localize with mitochondria,
cytochrome 
 
c
 
, and DRONC in serum-deprived cells even
before any morphological features of apoptosis became evi-
dent (Figs. 5 C and 6 B; unpublished data).
Figure 3. DRONC activation does not require cytochrome c 
release from mitochondria. BG2 cells treated with cycloheximide 
(A) or deprived of serum/insulin (B) for various lengths of time were 
gently lysed and fractionated by differential centrifugation to 
separate heavy membrane (P10, containing mitochondria), light 
membrane (P100), and cytosol (S100). Aliquots from each fraction 
were electrophoresed through 15% polyacrylamide gels and 
immunoblotted using an anti–cytochrome c monoclonal antibody 
(top), anti-DRONC polyclonal antibody (middle), or anti-DRICE 
polyclonal antibody (bottom). Signals were detected by ECL. The 
50- and 36-kD DRONC bands represent the precursor and processed 
forms of DRONC, respectively.
Figure 4. Cytochrome c is not released from 
mitochondria during BG2 cell apoptosis. BG2 
cells treated with cycloheximide for various 
durations were fixed and stained with the 
mitochondrial marker MitoTracker red, or 
immunostained with either anti–cytochrome c 
monoclonal antibody or polyclonal antibodies 
for DRONC or DRICE. After incubation with 
appropriate FITC-coupled secondary antibodies, 
cells were visualized by fluorescence microscopy. 
Note that the DRICE antibody used in these 
experiments only recognizes the processed active 
form of DRICE, and thus cells undergoing apoptosis 
show a more intense staining for DRICE than the 
control at 0 h.
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To ensure that lack of cytochrome c release during
apoptosis is not a cell- and signal-specific process, we also
used l(2)mbn cells (Ress et al., 2000) undergoing apopto-
sis in response to ecdysone treatment. Ecdysone treatment
of l(2)mbn cells results in transcriptional up-regulation of
dronc expression, followed by accumulation and process-
ing of proDRONC to p36 (unpublished data). RNAi ex-
periments have shown that DRONC up-regulation is es-
sential for ecdysone-mediated apoptosis of l(2)mbn cells
(unpublished data). Consistent with the results in BG2
cells, both cell fractionation and immunocytochemistry
experiments suggested that in l(2)mbn cells undergoing
ecdysone-mediated apoptosis, caspase activation occurred
without any significant release of cytochrome c (Fig. 7;
unpublished data).
DEBCL overexpression fails to cause
cytochrome c release
In mammals, members of the proapoptotic Bax subfamily of
proteins translocate from the cytosol to the mitochondrial
membrane and cause a release of cytochrome c during apop-
tosis (Gross et al., 1999; Kluck et al., 1999; for review see
Strasser et al., 2000; Wei et al., 2000). Recent studies have
shown that Bax and Bak coalesce into large clusters adjacent
to mitochondria (Nechushtan et al., 2001). In Drosophila,
there are two Bax-like proteins, DEBCL (also known as
Drob-1, dBorg, or dBok) and BUFFY (Brachmann et al.,
2000; Colussi et al., 2000; Igaki et al., 2000; Zhang et al.,
2000). Only DEBCL has been shown to be proapoptotic
(Brachmann et al., 2000; Colussi et al., 2000; Igaki et al.,
2000; Zhang et al., 2000). Overexpression of DEBCL in
transfected mammalian and Drosophila SL2 cells results in
its localization to mitochondria (Igaki et al., 2000; Zhang et
al., 2000). Overexpression of DEBCL in mammalian cells
has been shown to cause release of cytochrome c, suggesting
that DEBCL is functionally similar to Bax (Zhang et al.,
2000). To test whether DEBCL can induce release of cyto-
chrome c in insect cells, we transfected a hemagglutinin
(HA)-tagged DEBCL expression construct into BG2 cells.
As shown in Fig. 8 A, in transfected cells, DEBCL expres-
sion corresponds to the pattern of mitochondria, as assessed
by colocalization of DEBCL with cytochrome c. However,
there was no apparent release of cytochrome c in DEBCL-
transfected cells (Fig. 8, A–C). Interestingly, in transfected
Figure 5. DRONC and active DRICE partially colocalize with 
mitochondria in BG2 cells. BG2 cells treated with cycloheximide 
for various lengths of time were costained with anti-DRONC poly-
clonal antibody and either MitoTracker red (A) or anti–cytochrome 
c monoclonal antibody (B). After incubation with FITC- (DRONC) 
or rhodamine- (cytochrome c) coupled secondary antibodies, cells 
were visualized by fluorescence microscopy using appropriate 
filters. The last column depicts merged images of the DRONC and 
MitoTracker costaining (A) or DRONC and cytochrome c costaining 
(B). (C) BG2 cells treated with cycloheximide for 8 h were double 
stained for active DRICE (FITC) and cytochrome c (rhodamine).
Figure 6. Cytochrome c localization in BG2 cells is not altered 
after serum deprivation. (A) Untreated BG2 cells or those deprived 
of serum and insulin for 24 h were fixed and costained with anti-
DRONC polyclonal antibody and anti–cytochrome c monoclonal 
antibody. After incubation with FITC- (DRONC) or rhodamine- 
(cytochrome c) coupled secondary antibodies, cells were visualized 
by fluorescence microscopy using appropriate filters. The last 
column depicts merged images of the DRONC and cytochrome c 
costaining. (B) BG2 cells deprived of serum and insulin for various 
lengths of time were fixed and immunostained with anti-DRICE 
polyclonal antibody. As the anti-DRICE antibody only detects the 
active processed form of DRICE, immunofluorescence is seen in 
apoptotic cells only.
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Figure 7. Lack of cytochrome c release during ecdysone-
induced caspase activation in l(2)mbn cells. Drosophila 
l(2)mbn cells were treated with ecdysone for 24 h. 
After this, cells were either immunostained for active 
DRICE and cytochrome c (A) or fractionated (B) as in 
Fig. 3. After 24 h of ecdysone treatment, 80% of the 
cells were morphologically apoptotic and the majority 
of DRONC was processed into p36 (unpublished data). 
(A) Immunostaining with the active DRICE antibody 
clearly showed that cells contained processed DRICE. 
Please note that in B, the small amount of cytochrome c 
present in all cytosolic lanes is unlikely to represent 
cytochrome c released from mitochondria in cells 
undergoing apoptosis, as it does not show an increase 
over time. Furthermore, there was no reduction in the 
mitochondrial cytochrome c seen over the course of 
ecdysone treatment of cells.
cells, a large proportion of DRONC and active DRICE also
colocalized with DEBCL (Fig. 8, B and C). Cell fraction-
ation experiments confirmed that in DEBCL-transfected
cells, all cytochrome c remains largely associated with the
heavy membrane fraction (Fig. 8 D). It should, however, be
noted that only 10% of the cells are transfected with DE-
BCL, and at 24 h, 50% of the transfected cells were mor-
phologically apoptotic (consistent with previously reported
results with SL2 cells; Colussi et al., 2000). This may make
it difficult to see small amounts of cytosolic cytochrome c
and processed DRONC. However, active DRICE immu-
nostaining data suggested that all DEBCL-expressing cells
contain active caspase (Fig. 8 C; unpublished data).
DRONC forms a large complex in response to 
cytochrome c and dATP
In mammalian cell extracts, addition of cytochrome c and
dATP results in the formation of an 700-kD complex,
commonly known as an apoptosome (Cain et al., 1999,
2000). Studies using purified components have demon-
strated that the apoptosome, consisting of Apaf-1, cyto-
chrome c, and procaspase-9, is necessary for caspase-9 activa-
tion (Li et al., 1997; Cain et al., 1999; Rodriguez and
Lazebnik, 1999; Zou et al., 1999). As formation of an apop-
tosome in Drosophila has not been demonstrated and be-
cause cytochrome c is not released from mitochondria dur-
ing apoptosis, we tested whether a cytochrome c–dependent
apoptosome containing DRONC is formed in Drosophila
cells. Cell extracts prepared from BG2 cells were fraction-
ated by gel filtration chromatography and individual frac-
tions were analyzed by immunoblotting using specific anti-
bodies. In cell extracts kept at 4C, the majority of DRONC
was eluted in its monomeric form (50 kD) in fractions 20–
22 (Fig. 9). Extracts that were incubated at 27C with or
without cytochrome c and dATP showed a shift of some of
the DRONC protein to fractions 3–5, which correspond to
a molecular mass of 670 kD (Fig. 9 A). The shift in the
absence of added cytochrome c may suggest that endogenous
Figure 8. Ectopic expression of DEBCL does not induce cytochrome 
c release. BG2 cells were transfected with a DEBCL–HA expression 
construct. 24 h after transfection, cells were immunostained with an 
anti-HA monoclonal antibody and with either cytochrome c mono-
clonal antibody (A), the DRONC polyclonal antibody (B), or the 
active DRICE antibody (C). After incubation with FITC- (DEBCL–HA) 
or rhodamine- (cytochrome c and DRONC) coupled secondary 
antibodies, cells were visualized by fluorescence microscopy. The 
column on the right shows merged images of the DEBCL and cyto-
chrome c costaining (A), DEBCL and DRONC costaining (B), or 
DEBCL and active DRICE costaining (C). In C, note that the DEBCL-
expressing cell is positive for active DRICE. (D) Extracts prepared 
from DEBCL–HA-transfected BG2 cells were fractionated by 
centrifugation into heavy membranes (containing mitochondria), 
light membranes, and cytosol. Proteins were separated through 15% 
polyacrylamide gels and immunoblotted with an anti-HA mono-
clonal antibody (to detect DEBCL expression; top), anti–cytochrome 
c monoclonal antibody (middle), and anti-DRONC polyclonal 
antibody (bottom).
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cytochrome c present in cell extracts could be sufficient to al-
low the formation of the large complex containing DRONC
(see below). We have seen similar results using mammalian
cell extracts (unpublished data). Drosophila cells grow at
27C, however, when the cell extracts were incubated at
37C, the majority of the DRONC was recruited to the
700-kD complex and there was increased processing of
proDRONC and proDRICE. The reason for this is not
clear, however we have noticed that recombinant DRONC
and DRICE and extracts prepared from apoptotic BG2 cells
show considerably more caspase activities at 37C than at
27C (unpublished data).
We also determined whether the large complex contains
DRICE. In cell extracts incubated at 4C, the majority of
the DRICE precursor remained in its monomeric form, al-
though some appeared to be dimeric (Fig. 9 B). Incubation
of cell extracts at 27C or 37C, with or without cytochrome
c/dATP, resulted in the recruitment of a fraction of DRICE
to the high molecular mass complex (Fig. 9 B). Interestingly,
in extracts incubated at 37C, most of the DRICE in the
high molecular mass complex was processed, whereas most
of the monomeric DRICE was in the precursor form. These
results suggest the formation of an apoptosome containing
DRONC and DRICE in Drosophila cell extracts.
To further explore the role of cytochrome c in the forma-
tion of the DRONC-containing complex, we immunode-
pleted cytochrome c from S100 fractions (Fig. 10 A). These
fractions were then subjected to gel filtration experiments.
When incubated at 27C, a small fraction of DRONC was
found in the high molecular mass complex (Fig. 10 B). Addi-
tion of cytochrome c and dATP caused a significant increase
Figure 9. Formation of large molecular complexes containing 
DRONC and DRICE. BG2 cell extracts were supplemented with 2 
g cytochrome c, 2 mM dATP, and 1 mM MgCl2 and incubated for 
1 h at either 4C, 27C, or 37C. Extracts were then subjected to gel 
filtration chromatography using a Superdex 200 column. Individual 
fractions were collected and subjected to electrophoresis through 
15% polyacrylamide gels. Fractions were immunoblotted with 
anti-DRONC polyclonal antibody (A) and anti-DRICE polyclonal 
antibody (B), and proteins were detected by ECL. Relative positions 
of molecular mass markers are shown. Note that the incubation of 
cell extracts at 27C or 37C causes monomeric DRONC (50 kD) to 
form complexes of 700 kD. Also, recruitment of DRONC in the 
large complex results in its processing, as demonstrated by the 
presence of the 36-kD band. A fraction of DRICE, most of which is 
processed in extracts incubated at 37C, is also present in the complex.
Figure 10. Cytochrome c enhances formation of the 670-kD 
complex. BG2 S100 fraction were immunodepleted with cytochrome 
c, as shown in A, and then incubated for 1 h at 27C alone or 
supplemented with dATP, cytochrome c, or both dATP and 
cytochrome c (B and C). Cellular proteins were then subjected to 
gel filtration chromatography using a Superdex 200 column. 
Individual fractions were collected and subjected to electrophoresis 
through 15% polyacrylamide gels. Fractions were immunoblotted 
with anti-DRONC antibody (B) and anti–cytochrome c antibody, (C) 
and proteins were detected by ECL. Note that the immunodepleted 
S100 fraction lacks any detectable cytochrome c. Results in C show 
that only the dimeric (26 kD) form of cytochrome c is recruited to 
the 700-kD complex. Interestingly, a significant proportion of 
dimeric cytochrome c was detected in fractions 20–23, which 
corresponds to a molecular mass of 50 kD. This species may 
represent the tetrameric form of cytochrome c, which is composed 
of two dimers. The monomeric form (13 kD) of cytochrome c, 
eluted in fractions 33–39 (unpublished data), was not detected in 
high molecular mass fractions.
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in the recruitment of DRONC to the 700-kD complex.
Immunoblotting the fractions with the cytochrome c anti-
body showed that incubation of S100 at 27C results in the
recruitment of a significant proportion of cytochrome c to the
700-kD complex (Fig. 10 C). Interestingly, only dimeric
(26 kD) cytochrome c was detected in the 700-kD com-
plex. These results suggest that cytochrome c and dATP, at
least in part, are responsible for the formation of the complex.
Discussion
Release of cytochrome c from mitochondria is one of the key
steps in mediating caspase activation in mammalian cells
(for reviews see Green and Reed, 1998; Wang, 2001). How-
ever, consistent with a previous report (Varkey et al., 1999),
we do not find any cytochrome c in cytosolic fractions of
Drosophila cells undergoing apoptosis. Importantly, the
novel finding reported in this paper is that endogenous
DRONC activation can occur during apoptosis without any
apparent cytochrome c in the cytosolic fraction, suggesting
that cytochrome c release from mitochondria is not required
for DRONC activation. Similarly, DRICE, the downstream
target of DRONC, was also activated in the absence of cyto-
solic cytochrome c, further confirming that caspase activa-
tion in Drosophila cells occurs without the release of cyto-
chrome c from mitochondria.
Treatment of cells with multiple death stimuli, including
cycloheximide, factor withdrawal, ecdysone, or transfection
of the Bax-like protein DEBCL, failed to induce the release
of detectable cytochrome c. Our immunolocalization stud-
ies suggest that cytochrome c remained associated with mi-
tochondria in cells undergoing apoptosis. Moreover, the
mitochondria appeared remarkably intact even in late stage
apoptotic cells. However, in some cells undergoing apopto-
sis there appeared to be an accumulation of mitochondria
in the perinuclear region of the cells, which is similar to
that reported in mammalian cells expressing truncated Bid
(Li et al., 1998). Interestingly, a fraction of endogenous
DRONC colocalized with mitochondria. Cell fractiona-
tion studies suggest that a significant proportion of the
DRONC precursor and processed DRONC is associated
with both the mitochondrial membrane fraction and the
light membrane fraction. Therefore, it is possible that
membrane recruitment of DRONC is important for its ac-
tivation. Overexpression of DEBCL results in its localiza-
tion to mitochondria (Igaki et al., 2000; Zhang et al.,
2000). Again, in the DEBCL-overexpressing cells, a frac-
tion of DRONC appeared to colocalize with mitochondria
and DEBCL, suggesting that translocation of DRONC
may be important for caspase activation.
If cytochrome c is not released from mitochondria dur-
ing apoptosis, how may caspase activation occur in Dro-
sophila cells? Previous work using cytochrome c monoclo-
nal antibodies has shown that in Drosophila egg chambers
and in SL2 cells, cytochrome c undergoes conformational
changes within the mitochondria before the onset of apop-
tosis (Varkey et al., 1999). However, cytochrome c was not
released from mitochondria during apoptosis, as we have
found in our studies with BG2 and l(2)mbn cells. This is in
contrast to apoptosis in mammalian cells where cyto-
chrome c release from mitochondria is rapid and complete
(Green and Reed, 1998; Goldstein et al., 2000). The work
by Varkey et al. (1999) also demonstrates that mitochon-
dria isolated from apoptotic SL2 cells can mediate caspase
activation in vitro. These results suggest that although both
mitochondria and cytochrome c play a role in apoptosis, in
Drosophila, cytochrome c release from mitochondria does
not occur. One possibility is that cytochrome c is released
but remains tethered to the mitochondrial membrane (Var-
key et al., 1999). In such a case, an apoptosome, albeit
somewhat different from the mammalian apoptosome,
may form in the vicinity of mitochondria. Our observa-
tions that in BG2 cells undergoing apoptosis, mitochon-
dria become somewhat clustered and a significant propor-
tion of DRONC colocalizes with mitochondria support
this possibility. Because proapoptotic proteins such as DE-
BCL and Hid also localize to mitochondria, mitochondria
clearly play a role in apoptosis in Drosophila.
We explored the possibility of apoptosome formation by
gel filtration of BG2 cell extracts and testing for recruitment
of DRONC to high molecular mass complexes. Incubation
of BG2 cell extracts containing endogenous cytochrome c
at 27C–37C resulted in the recruitment of cytosolic
DRONC to a complex of 700 kD. Furthermore, a large
fraction of DRONC in the complex was in processed form,
suggesting that recruitment to the putative apoptosome may
be necessary for DRONC activation. Interestingly, a signifi-
cant proportion of DRICE was also found in the 700-kD
complex, most of which was fully processed when extracts
were incubated at 37C. As DRICE has been shown to di-
rectly interact with DRONC, the recruitment of DRICE
may be required for the initial DRONC-mediated activation
of DRICE. This prediction is consistent with the studies
with caspase-9/Apaf-1 apoptosome, which also mediates the
initial activation of caspase-3 (Bratton et al., 2001).
Given that cytochrome c is not released from mitochon-
dria in Drosophila cells, yet cytochrome c addition to Dro-
sophila cell extracts can enhance the formation of an apopto-
some-like complex and caspase activation, it is reasonable to
hypothesize that caspase activation in insects follows a more
primitive mechanism, which may be the precursor to the
caspase activation pathways in mammals. However, our data
presented in this paper does not rule out the possibility that
a factor(s) other than cytochrome c may be involved in cas-
pase activation in Drosophila cells. In future studies, the elu-
cidation of the exact nature of the Drosophila apoptosome
may shed light on the mechanism of apoptosome formation
and caspase activation.
Materials and methods
Cell culture
Drosophila BG2 cells derived from larval central nervous system (Ui-Tei et
al., 2000) were obtained from K. Ui-Tei (Nippon Medical School, Tokyo,
Japan). Cells were maintained in Schneider’s cell medium (GIBCO BRL)
supplemented with a 0.5% penicillin–streptomycin mix (GIBCO BRL),
10% heat-inactivated FBS, 1% glutamine (GIBCO BRL), and 10 g/ml in-
sulin (Novartis). Cells were cultured at a density of 106 cells/ml at 27C.
l(2)mbn cells (gift from A. Dorn, Johannes Gutenberg University, Mainz,
Germany; Ress et al., 2000) were also grown in Schneider’s medium sup-
plemented with 10% FBS. Cells, 1.5  106/well, were seeded in six-well
plates and treated with ecdysone (10 M; Sigma) for the desired time.
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Cell death and caspase processing assays
5  106 cells were washed in PBS and incubated with 20 g/ml cyclohex-
imide (Sigma-Aldrich) or were grown in medium depleted of FBS and insu-
lin. Cells were harvested at various time points after apoptotic induction
and the number of surviving cells was estimated by trypan blue exclusion.
For immunoblotting with caspase antibodies, cells were centrifuged at
400 g for 5 min and pellets were resuspended in 50 l PBS, mixed with an
equal volume of 2 SDS protein loading buffer (100 mM Tris-HCl, pH 6.8,
200 mM DTT, 4% SDS, 0.2% bromophenol blue, 20% glycerol), and then
boiled for 10 min before SDS-PAGE.
Caspase assays
Cells were harvested and resuspended in 100 l caspase assay buffer
(0.1 M Hepes, pH 7, 0.1% CHAPS, 10% PEG4000, 10 mM DTT, supple-
mented with 1 protease inhibitor cocktail; Roche Biochemicals). Cells
were lysed by three cycles of freeze–thawing. Cell debris was centrifuged at
9,000 g for 10 min at 4C. The cleared lysates (100 g) were assessed for
caspase activity by incubation with 100 M of either DEVD-7-amino-4-
methylcoumaride (DEVD-amc; Enzyme System Products) or VDVAD-amc
(California Peptide Research) in a total volume of 40 l in caspase assay
buffer at 37C for 30 min. We also tested caspase activity at 27C because
Drosophila cells grow at this temperature. However at 27C, measured cas-
pase activity was considerably lower. Reactions were transferred to acryl cu-
vettes (Sarstedt), and 3 ml water was added before analysis on a lumines-
cence spectrometer (excitation 385 nm, emission 460 nm; PerkinElmer).
RNA interference
Regions of cDNA for dronc (nt 781–1047), dark (nt 3603–3962), and the
negative control mouse N4WBP5 (700-bp coding region; Harvey et al.,
2002) were PCR amplified using appropriate primers, and cloned into
pGEM-T Easy (Promega). Plasmids were linearized and RNA synthesized
using T7 and SP6 Megascript kits (Ambion). Sense and antisense strands
were annealed to generate dsRNA, and RNA quality was analyzed on aga-
rose gel. dsRNA (37 nM) was added to cells in 1 ml serum-free media and
mixed vigorously. Cells were incubated for 1 h followed by the addition of
2 ml of media supplemented with 10% FBS. Cells were incubated over-
night and then treated with cycloheximide for 6 h before cell lysis and im-
munoblotting.
Cell fractionation
5  106 cells were harvested by centrifugation at 400 g for 5 min. Cell
pellets were resuspended in 200 l of lysis buffer A (20 mM Hepes-
KOH, pH 7.5, 50 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1
mM DTT in 250 mM sucrose and supplemented with protease inhibitor
cocktail) and incubated on ice for 5 min. Cells were homogenized by 10
strokes with a tight fitting pestle, and homogenates were centrifuged
twice at 500 g for 10 min at 4C. Pellets, consisting of unbroken cells
and nuclei, were retained and resuspended in 100 l PBS. The superna-
tants were centrifuged at 10,000 g for 15 min at 4C, and the heavy
membrane/mitochondrial pellets were washed in cold buffer, resus-
pended in 30 l lysis buffer A, and stored at 70C. Supernatants were
further centrifuged at 100,000 g for 30 min at 4C. The resulting pellets
(P100) consisting of light membrane fractions were resuspended in 30
l lysis buffer A and stored at 70C. Resulting supernatants (S100)
were also stored at 70C. For protein gel analysis, 4 SDS protein
loading buffer was added to each fraction and samples were resolved on
8–15% SDS-PAGE gels.
Affinity purification of DRONC antibodies
Anti-DRONC rabbit polyclonal sera was passed through a column of
glutathione-S-transferase (GST) coupled to cyanogen bromide–activated
Sepharose 4 (Amersham Pharmacia Biotech) to remove GST-specific anti-
bodies. Flowthrough from this step was affinity purified against DRONC
p14–GST (Quinn et al., 2000) coupled to cyanogen bromide–activated
Sepharose 4. Bound proteins were eluted into Tris-HCl (pH 8.6) with 100
mM glycine (pH 2.5) and dialyzed against PBS. Affinity-purified antibodies
were diluted in 50% glycerol and stored at 20C.
Generation and affinity purification of anti–active
DRICE antibodies
Active DRICE–specific antibodies used in immunofluorescence studies
(Figs. 4–8) were raised in rabbits using a synthetic octapeptide correspond-
ing to the COOH terminus of the DRICE large subunit (QRSQTETD) conju-
gated with keyhole limpet hemocyanin as the immunogen (Covance). Ac-
tive DRICE–specific antibodies were purified by sequential protein affinity
purification. Antisera were first applied to an affinity column containing
full-length DRICE with an inactivating active site mutation (C211A). The
flowthrough from this column was applied to an affinity column contain-
ing the DRICE large subunit ending at the caspase cleavage site TETD
(1–230). Bound antibody was eluted using 100 mM glycine, pH 2.5. Im-
munoblotting of the eluted anti-DRICE antibodies showed that they were
specific for the cleaved large subunit of active DRICE. They did not detect
full-length DRICE or other caspases, including the closely related DCP-1
(unpublished data).
A second rabbit anti-DRICE polyclonal antibody, used for immunoblot-
ting, was generated using a version of DRICE that extends from residue 80
to the COOH terminus, followed by a COOH-terminal 6 His tag as the
immunogen. DRICE-reactive antibodies were purified by binding this se-
rum with the antigen and washing extensively. DRICE-reactive antibodies
were eluted as above for the DRICE cleavage-specific antibodies.
Immunoblotting
After SDS-PAGE, protein was transferred to a PVDF membrane (Dupont).
The membranes were blocked in 5% skim milk (Diploma)–PBS/0.05%
Tween 20 solution overnight at 4C. Blots were incubated with 0.5 g/ml
anti–cytochrome c mouse antibody 7H8.2C12 (BD PharMingen), 1.5 g/
ml affinity-purified anti-DRONC rabbit antibody, 0.1 g/ml anti-HA
mouse antibody (Roche Biochemicals), or 1.5 g/ml anti-DRICE rabbit an-
tibody, followed by incubation with the corresponding HRP-conjugated
secondary antibody. Signals were visualized by ECL (Amersham Pharma-
cia Biotech).
Immunofluorescence
2  106 cells were grown on coverslips in 35-mm dishes. After apoptotic
induction, cells were washed in PBS. For MitoTracker staining, cells were
incubated with 300 nM MitoTracker red (Molecular Probes) in PBS with
1% FBS for 15 min at room temperature (RT). Coverslips were either
mounted on slides in antifade solution (80% glycerol, 1% propylgalate) or
were fixed with 3% paraformaldehyde for 10 min at RT, washed in PBS,
and then permeabilized in 0.1% Triton X-100 for 10 min at RT before anti-
body staining. Cells were costained with anti–cytochrome c mouse anti-
body clone 6H2.B4 (BD PharMingen) at 2.5 g/ml, affinity-purified
anti-DRONC rabbit antibody at 4 g/ml, and/or anti-HA high affinity rat
antibody (Roche Biochemicals) at 1 g/ml and anti–active DRICE antibody
at 4 g/ml. All antibodies were diluted in PBS (0.1% FBS) and incubated
with cells overnight at 4C. Cells were then washed three times in PBS and
incubated with FITC-conjugated anti–mouse, –rabbit, or –rat secondary
antibodies and rhodamine-conjugated anti–rabbit or –mouse antibodies
for 1 h at RT. Cells were again washed several times in PBS and coverslips
were mounted onto slides in antifade solution. Cell staining was visualized
under fluorescent microscopy.
Gel filtration chromatography
108 BG2 cells were resuspended in 200 l buffer A (20 mM Hepes-KOH,
pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM
DTT supplemented with protease inhibitor cocktail; Zou et al., 1999) and
lysed by freeze–thaw. Cell debris was pelleted twice by centrifugation at
10,000 g for 20 min at 4C. Supernatants were further centrifuged at
100,000 g for 30 min at 4C. Resulting lysates (S100) were incubated
at 4C, 27C, or 37C alone or in the presence of 2 g cytochrome c and
2 mM dATP. Proteins were then fractionated through a Superdex 200
column (Amersham Pharmacia Biotech). Fractions were collected 18 min
after sample injection and a total of 42 fractions were collected at a rate
of 0.4 ml/fraction/min. Aliquots from each fraction were resolved by
electrophoresis through 8–15% polyacrylamide gels. For immunodeple-
tion of cytochrome c, S100 lysates were incubated overnight at 4C with
an anti–cytochrome c antibody 6H2 (BD PharMingen). Antigen–antibody
complexes were removed by protein G–Sepharose, and cytochrome
c–depleted extracts were fractionated through a Superdex 200 column
after incubation at 27C alone or in the presence of 2 g cytochrome c
and 2 mM dATP.
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